1Angus DC,Linde-Zwirble WT,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome, and associated costs of care.Crit Care Med, 2001,29:1303-1310.
2Medzhitov R, Janeway CA. Innate immune recognition:mechanisms and pathways. Immunological Reviews,2000,173:89-97.
3Taguchi T,Mitcham JL, Dower SK,et al.Chromosomal localization of TIL,a gene encoding a protein related to the Drosophila transmembrane receptor Toll ,to human chromosome 4p14.Genomics,1996,32:486-488.
4Medzhitov R, Preston-Hurlburt PJaneway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity.Nature, 1997,388:394-397.
5Lien E,Ingalls RR.Toll-like receptors.Crit Care Med,2002,30:s1-s11.
6Armstrong L, Medford AR, Hunter KJ,et al.Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in humansepsis.Clin Exp Immunol,2004,136:312-319.
7Holmes CL Russell JA, Walley KR.Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy. Chest,2003,124:1103-1115.
8Poltorak A,He X,Smirnova I,et al.Defeetive LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in TLR4 gene.Science,1998,282 : 2085-2088.
9Child NJ,Yang IA,Pulletz MC,et al.Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochem Soc Trans,2003,31:652-653.
10Williams DL, Ha T,Li C,et al.Modulation of tissue Toll-like receptor 2 and 4 during the early phases of polymicrobial sepsis correlates with mortality.Crit Care Med,2003,31 : 1808-1818.
3Lu LF, Liston A. MicroRNA in the immune system, microRNA as an immune system[J]. Immunology, 2009, 127(3) : 291 -298.
4Deho L, Monticelli S. Human mast cells and mastocytosis: har- nessing microRNA expression as a new approach to therapy [ J ]. Arch Immunol Ther Exp ( Warsz), 2010, 58 ( 4 ) : 279 - 286.
5Bi Y, Liu G, Yang R. MicroRNAs: novel regulators during the immune response [ J ]. J Cell Physiol, 2009, 218 ( 3 ) : 467 - 472.
6Zhou B, Wang S, Mayr C, et al. miR - 150, a microRNA ex- pressed in mature B and T cells, blocks early B cell development when expressed prematurely [ J ]. PNAS, 2007, 104 ( 17 ) : 7080 - 7085.
7Vasilescu C, Rossi S, Shimizu M, et al. MicroRNA fingerprints identify miR - 150 as a plasma prognostic marker in patients with Sepsis[ J]. PLoS One, 2009, 4(10): e7405.
8Roderburg C, Luedde M, Vargas Cardenas D, et al. Circulating mieroRNA - 150 serum levels predict survival in patients with critical illness and sepsis[J]. PLoS One, 2013, 8(1) : e54612.
9OConnell RM, Taganov KD, Boldin MP, et al. MiemRNA - 155 is induced during the maerophage inflammatory response [ J ]. Proe Natl Aead Sei U S A, 2007, 104(5) : 1604 -1609.
10Tili E, MichaiUe JJ, Cimino A, et al. Modulation of miR - 155 and miR -125b levels following lipopolysaccharide/TNF- alpha stimulation and their possible roles in regulating the response to endotoxin shock [ J]. J Immunol, 2007, 179 (8) : 5082 - 5089.
